Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 982 of 5804
-
New drug targets Hard-to-Treat uterine cancer in small trial
Disease control Recruiting nowThis study is testing a drug called enfortumab vedotin in up to 12 patients with advanced endometrial (uterine) cancer that has worsened after previous treatments, including immunotherapy. The goal is to see how well the drug works and how safe it is. Patients will be treated for…
Phase: PHASE2 • Sponsor: William Bradley • Aim: Disease control
Last updated Jul 15, 2026 00:00 UTC
-
Could exercise reshape gut bacteria in fatty liver disease?
Disease control Not yet recruitingTo compare High-Intensity Interval Training versus moderate intensity continuous training on gut microbiota in Non- Alcoholic Fatty Liver.
Phase: NA • Sponsor: Horus University • Aim: Disease control
Last updated Jul 15, 2026 00:00 UTC
-
New study aims to uncover hidden heart risks in CKM syndrome
Knowledge-focused Not yet recruitingCardiovascular-kidney-metabolic (CKM) syndrome is a systemic disorder characterized by pathophysiological interactions among metabolic risk factors, chronic kidney disease, and the cardiovascular system, leading to multiorgan dysfunction and increased risk of atrial fibrillation,…
Sponsor: Grigore T. Popa University of Medicine and Pharmacy • Aim: Knowledge-focused
Last updated Jul 15, 2026 00:00 UTC
-
Can a 10-Minute daily app boost teen mental health?
Symptom relief Not yet recruitingThis study aims to evaluate the validity and effectiveness of NEMO-I (Neuro-cognitive Emotion Monitoring-Intervention), a mobile application designed to help adolescents monitor and manage their cognitive and emotional functioning in everyday settings. NEMO-I delivers evidence-ba…
Phase: NA • Sponsor: Seoul Women's University • Aim: Symptom relief
Last updated Jul 16, 2026 00:00 UTC
-
Volunteers to be deliberately exposed to omicron in quest for better vaccines
Knowledge-focused Recruiting nowCOVHIC003 is a human infection challenge study in which healthy adults aged 18-50 previously vaccinated with an approved COVID-19 vaccine will be administered a SARS-CoV-2 Omicron EG.5.1 variant given by drops in the nose. The aim is to achieve breakthrough upper-respiratory infe…
Phase: PHASE1 • Sponsor: Imperial College London • Aim: Knowledge-focused
Last updated Jul 19, 2026 00:00 UTC
-
New COPD inhaler HSK39004 tested for Long-Term safety in 300 patients
Disease control Not yet recruitingThis clinical trial evaluates the long-term safety and efficacy of 3 mg HSK39004 Inhalation Suspension administered twice daily for 52 weeks in subjects aged 40 to 80 years with moderate-to-severe stable chronic obstructive pulmonary disease (COPD).
Phase: PHASE3 • Sponsor: Haisco Pharmaceutical Group Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 13:05 UTC
-
Laser light may ease Pinched-Nerve pain without surgery
Symptom relief Recruiting nowThe study aims to evaluate the effectiveness of high-power laser therapy (HPLT) in patients with cervical radiculopathy, focusing on its impact on disc morphology, and overall functional activity
Phase: NA • Sponsor: Cairo University • Aim: Symptom relief
Last updated Jul 09, 2026 00:00 UTC
-
Could this pill protect kidneys in diabetes?
Disease control Recruiting nowGoal: The goal of this clinical trial is to learn if the investigational drug HTD1801 can slow the progression of kidney damage in adults diagnosed with both Type 2 Diabetes (T2DM) and Chronic Kidney Disease (CKD). Main Question it Aims to Answer: ▪ Does HTD1801 result in a gre…
Phase: PHASE2 • Sponsor: Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences • Aim: Disease control
Last updated Jul 17, 2026 00:00 UTC
-
New PARP1 inhibitor targets Hard-to-Treat cancers
Disease control Not yet recruitingThis is a Phase 1, open-label, multicenter study to evaluate the safety, tolerability, pharmacokinetics (PK), and pharmacodynamics (PD) of HSK46256 tablets, a selective PARP1 inhibitor, in patients with advanced solid tumors. The study consists of a dose escalation phase and a do…
Phase: PHASE1 • Sponsor: Haisco Pharmaceutical Group Co., Ltd. • Aim: Disease control
Last updated Jul 12, 2026 00:00 UTC
-
New PET tracer could spot hidden fungal infections
Diagnosis Recruiting nowBackground: Fungal infections can cause serious disease in the lungs and other parts of the body. About 3.8 million people die with fungal infections each year. Currently, there is no way to find fungal infections in the body using imaging scans. Researchers want to see if a new…
Phase: PHASE1 • Sponsor: National Institutes of Health Clinical Center (CC) • Aim: Diagnosis
Last updated Jul 19, 2026 00:00 UTC
-
New drug combo targets tough leukemia in early trial
Disease control Not yet recruitingThe purpose of this study is to evaluate the safety and tolerability of mezigdomide in combination with ziftomenib in adolescent and adult participants with either KMT2A-rearranged (KMT2A-r) or NPM1-mutant relapsed or refractory acute myeloid leukemia (AML).
Phase: PHASE1 • Sponsor: Massachusetts General Hospital • Aim: Disease control
Last updated Jun 27, 2026 08:13 UTC
-
Brain training without drugs: can imagining movement ease MS pain?
Symptom relief Not yet recruitingMany types of pain can occur in Multiple Sclerosis (MS), one of the most common types is neuropathic pain. Neuropathic pain is directly related to the disease's demyelination process and is associated with dysesthetic pain, allodynia, hyperalgesia. For neuropathic pain in MS, the…
Phase: NA • Sponsor: Uludag University • Aim: Symptom relief
Last updated Jul 19, 2026 00:00 UTC
-
One therapy to tackle two conditions: a trial combines exposure and habit reversal for tourettic OCD
Symptom relief Recruiting nowObsessive-Compulsive Disorder and Tic Disorders frequently co-occur, and a subgroup of patients - those with a Tourettic Subtype of OCD (TOCD) - present with symptoms of both conditions simultaneously. Standard interventions typically address one condition or the other, but rarel…
Phase: NA • Sponsor: University College London Hospitals • Aim: Symptom relief
Last updated Jul 26, 2026 00:00 UTC
-
New hope for lung scarring? drug trial aims to slow breathing decline
Disease control Recruiting nowThe purpose of this study is to evaluate the efficacy, safety, and tolerability at Week 24 of 2 doses of CHF10067 (zampilimab) in participants with idiopathic pulmonary fibrosis (IPF). It is a phase IIb, multicentre, randomised, double-blind, placebo-controlled, three-arm parall…
Phase: PHASE2 • Sponsor: Chiesi Farmaceutici S.p.A. • Aim: Disease control
Last updated Jul 18, 2026 00:00 UTC
-
Could a Head-Zap device ease fibromyalgia pain at home?
Symptom relief Recruiting nowThe purpose of this randomized controlled trial is to investigate the non-inferiority, and possible superiority, of a high-dose home-based tDCS protocol compared with a conventional home-based protocol, and to assess its cost-effectiveness, in patients with fibromyalgia. As comp…
Phase: NA • Sponsor: Ionclinics & Deionic SL • Aim: Symptom relief
Last updated Jul 17, 2026 00:00 UTC
-
Brain training may help prevent alcohol relapse after withdrawal
Disease control Not yet recruitingTUA-VelCo is a single-center randomized controlled superiority trial with blinded methodological assessment. Adult patients hospitalized for alcohol withdrawal and meeting the criteria for Alcohol Use Disorder (AUD) according to the Diagnostic and Statistical Manual of Mental Dis…
Phase: NA • Sponsor: Centre Hospitalier Esquirol • Aim: Disease control
Last updated Jul 12, 2026 00:00 UTC
-
Electric zaps to the forehead may help restore lost sense of smell
Symptom relief Not yet recruitingSmell dysfunction significantly impacts quality of life and safety, with limited effective treatments. This open-label study evaluates the preliminary efficacy of combining non-invasive trigeminal nerve stimulation (TNS) with standard smell training (ST) to improve olfactory func…
Phase: PHASE2 • Sponsor: Medical University of South Carolina • Aim: Symptom relief
Last updated Jul 11, 2026 00:00 UTC
-
Hormones may change how HIV prevention drug works in the body
Knowledge-focused Recruiting nowThis is a research study to better understand how long-acting cabotegravir (CAB-LA) works to prevent HIV in people. This study will also evaluate the impact of endogenous and therapeutic hormones on CAB-LA pharmacology. The investigators will also evaluate if participants experie…
Phase: PHASE1 • Sponsor: Johns Hopkins University • Aim: Knowledge-focused
Last updated Jul 15, 2026 00:00 UTC
-
Can a computer program teach teens to drink less?
Disease control Recruiting nowThis 8-week clinical trial will test a computer-based skills training program called Path180 with 112 adolescents aged 13 to 19 who are receiving mental health counseling or outpatient substance use treatment. Participants will be randomly assigned to either standard treatment (t…
Phase: NA • Sponsor: Brown University • Aim: Disease control
Last updated Jul 22, 2026 00:00 UTC
-
New hair loss drug enters final testing phase
Disease control Not yet recruitingThe purpose of this study is to evaluate the efficacy and safety of APSMNF in the treatment of male androgenetic alopecia.
Phase: PHASE3 • Sponsor: Apsen Farmaceutica S.A. • Aim: Disease control
Last updated Jun 27, 2026 12:06 UTC